Fully Integrated Biopharmaceutical Company (FIBCO) Model
A business structure where a single company controls the entire drug lifecycle in-house, from discovery and clinical development through manufacturing, regulatory approval, and commercialization, rather than outsourcing or partnering for specific stages of the value chain.
What is the Fully Integrated Biopharmaceutical Company (FIBCO) Model?
The Fully Integrated Biopharmaceutical Company (FIBCO) Model is a business structure in which a single company controls the entire drug lifecycle in-house. That span runs from early discovery and clinical development through manufacturing, regulatory approval, and ultimately commercialization.
Rather than outsourcing or partnering for individual stages, a FIBCO keeps each major capability under one roof. This contrasts with more specialized or virtual models that license assets or rely heavily on external partners for development, production, or sales.
Why does the FIBCO Model matter?
Owning the full value chain gives a company tighter control over its products, its pipeline, and the value it captures, since it does not have to share economics with partners at every stage. It can coordinate strategy end to end without depending on outside organizations.
The trade-off is the substantial capital, infrastructure, and risk required to build and sustain capabilities across discovery, manufacturing, and commercialization. The model therefore tends to suit larger, well-resourced organizations, and the choice for or against it shapes how a biopharmaceutical company is built and financed.
- fibco meaning
- what is the fibco model
- fully integrated biopharmaceutical company
- fibco vs virtual biotech
- fibco business model
- fully integrated biopharma model